National rates of initiation and intensification of antidiabetic therapy among patients with commercial insurance

Gilstrap LG et al. Diabetes Care 2018. doi: 10.2337/dc17-2585

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.2337/dc17-2585